FX006
Sponsors
Pacira Pharmaceuticals, Inc, The University of Texas Health Science Center, Houston
Conditions
Adhesive CapsulitisOsteoarthritis of the KneeOsteoarthritis of the ShoulderOsteoarthritis, HipTrochanteric Bursitis
Phase 2
Study of FX006 in Patients With Osteoarthritis of the Knee
CompletedNCT01487161
Start: 2012-06-30End: 2013-04-30Updated: 2024-01-24
Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis
TerminatedNCT04160091
Start: 2019-11-07End: 2020-06-15Updated: 2024-01-24
Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis
CompletedNCT04182672
Start: 2020-08-12End: 2022-12-14Updated: 2024-01-02
Phase 3
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
CompletedNCT02357459
Start: 2015-01-31End: 2016-01-31Updated: 2024-01-24
Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis
TerminatedNCT03793010
Start: 2018-12-12End: 2019-08-07Updated: 2024-01-24